MedPath

Virtual Pain Care Trial

Not Applicable
Conditions
Wound
Wound and Injuries
Pain
Interventions
Device: Virtual Reality ('VRelax' VR system)
Registration Number
NCT05772468
Lead Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Brief Summary

The main objective of this study is to evaluate the effect on pain of Virtual Reality Therapy as add-on therapy during wound care procedures in adults.

Detailed Description

After inclusion and completion of the informed consent form, patients are randomly allocated to the intervention group or control group in a 1:1 ratio. Randomization will not be blinded since both the provider and patient know if the patient will be wearing the VR system during wound care or not wearing the VR system.

Patients are randomly assigned to one of two groups:

Group 1 - Intervention group 1, Virtual Reality Therapy Group 2 - Control group, care as usual

Recruitment & Eligibility

Status
ENROLLING_BY_INVITATION
Sex
All
Target Recruitment
32
Inclusion Criteria
  • Individuals aged 18 or older with wounds receiving wound care
  • Individuals who will undergo minimum of 1 to a maximum of 3 sequential complex wound care procedures
  • At least 1 prior painful wound care procedure, where they have indicated a VAS ≥ 4, or patients reporting a VAS ≥ 4 before initiating the wound care procedure.
Exclusion Criteria
  • Individuals not being able to understand Dutch language at primary school level
  • Individuals not being able to read or write Dutch
  • Individuals diagnosed with dementia and/or cognitive impairment
  • Individuals diagnosed with epilepsy
  • Individuals diagnosed with migraine
  • Individuals with severe dizziness and/or nausea
  • Individuals with a known history of claustrophobia
  • Individuals who are unable to sign informed consent owing to mental disorder or formally stated to be incompetent to decide
  • Individuals who have no feeling in the wound care area
  • Individuals with physical (and/or cognitive) disabilities on the face, eye, ear, nose and neck that prevent the use of the VR headgear and/or headphones

Study & Design

Study Type
INTERVENTIONAL
Study Design
SEQUENTIAL
Arm && Interventions
GroupInterventionDescription
Virtual Reality Therapy (Intervention group 1)Virtual Reality ('VRelax' VR system)In addition to the standard wound care procedure, the Virtual Reality Therapy group (intervention group 1) will receive the VR system during the wound care. The VR system consists of Virtual Reality glasses, and a headphone. The application VRelax will be used, which will contain various videos for the patient those from to relax and be distracted. This group wears the VR system 10 minutes before the start of the wound care, until 1 minute after the wound care has ended.
Primary Outcome Measures
NameTimeMethod
The primary outcome is the change in pain score before and after the first wound care, measured with the Visual Analogue Scale (VAS).Baseline, during the procedure, immediately after procedur

The VAS is a horizontal scale from 0 to 10, with 0 indicating ''no pain'' and 10 indicating ''worst pain possible''.

Secondary Outcome Measures
NameTimeMethod
Mean VAS change of all wound care procedures included in the studyBaseline, during the procedure, immediately after procedure

The VAS is a horizontal scale from 0 to 10, with 0 indicating ''no pain'' and 10 indicating ''worst pain possible''.

Provider satisfactionThrough study completion, an average of 1 year

Provider satisfaction, as measured by a self-developed Dutch provider satisfaction questionnaire, focuses on satisfaction about the intervention with the VR system or headphone with audio. The questionnaires included a Visual Analogue Scale (VAS). The VAS is a horizontal scale from 0 to 10, with 0 indicating ''the worst score'' and 10 indicating ''the best score'', or with 0 indicating '''the best score'' and 10 indicating ''the worst score''.

Change from baseline pulse rate at 5 minutes after procedureBaseline, 5 minutes after procedure

The pulse rate 5 minutes before intervention (intervention group)/wound care (control group), and 5 minutes after the intervention (intervention group)/wound care (control group)

Change from baseline blood oxygen level at 5 minutes after procedureBaseline, 5 minutes after procedure

The blood oxygen level, measured using a pulse oximetry device, 5 minutes before intervention (intervention group)/wound care (control group), and 5 minutes after the intervention (intervention group)/wound care (control group)

Change of blood oxygen level during procedureDuring procedure

The blood oxygen level, measured using a pulse oximetry device, every 5 minutes during procedure

Change from baseline in level of anxiety at 10 minutes after procedureBaseline, 10 minutes after procedure

Level of anxiety, as measured by a Dutch translated and validated modification of the Spielberger State-Trait Inventory-6 (STAI-6) questionnaire 10 minutes before and 10 minutes after each three wound care moments.

Change from baseline systolic blood pressure and diastolic blood pressure at 5 minutes after procedureBaseline, 5 minutes after procedure

The systolic blood pressure and diastolic blood pressure 5 minutes before the intervention (intervention group)/wound care (control group) and 5 minutes after the intervention (intervention group)/wound care (control group)

Change of systolic blood pressure and diastolic blood pressure during procedureDuring procedure

The systolic blood pressure and diastolic blood pressure every 5 minutes during procedure

Change of respiratory rate during procedureDuring procedure

The respiratory rate every 5 minutes during procedure

Change of pulse rate during procedureDuring procedure

The pulse rate every 5 minutes during procedure

Patient satisfactionThrough study completion, an average of 1 week

Patient satisfaction, as measured by a self-developed Dutch provider satisfaction questionnaire, focuses on satisfaction about the intervention with the VR system or headphone with audio. The questionnaires included a Visual Analogue Scale (VAS). The VAS is a horizontal scale from 0 to 10, with 0 indicating ''the worst score'' and 10 indicating ''the best score'', or with 0 indicating '''the best score'' and 10 indicating ''the worst score''.

Change from baseline respiratory rate at 5 minutes after procedureBaseline, 5 minutes after procedure

The respiratory rate 5 minutes before intervention (intervention group)/wound care (control group), and 5 minutes after the intervention (intervention group)/wound care (control group)

Trial Locations

Locations (1)

Amsterdam University Medical Center

🇳🇱

Amsterdam, Noord-Holland, Netherlands

© Copyright 2025. All Rights Reserved by MedPath